These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21606880)

  • 1. Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
    Mithani SK; Smith IM; Califano JA
    Melanoma Res; 2011 Aug; 21(4):298-307. PubMed ID: 21606880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
    Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
    BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells.
    Lee YK; Park UH; Kim EJ; Hwang JT; Jeong JC; Um SJ
    Cancer Lett; 2017 Sep; 403():144-151. PubMed ID: 28634046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
    Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
    Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX4 has the potential to function as a tumor suppressor in human melanoma.
    Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
    Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.
    van der Velden PA; Zuidervaart W; Hurks MHMH; Pavey S; Ksander BR; Krijgsman E; Frants RR; Tensen CP; Willemze R; Jager MJ; Gruis NA
    Int J Cancer; 2003 Sep; 106(4):472-479. PubMed ID: 12845640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications.
    Halaban R; Krauthammer M; Pelizzola M; Cheng E; Kovacs D; Sznol M; Ariyan S; Narayan D; Bacchiocchi A; Molinaro A; Kluger Y; Deng M; Tran N; Zhang W; Picardo M; Enghild JJ
    PLoS One; 2009; 4(2):e4563. PubMed ID: 19234609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
    Mori T; Kim J; Yamano T; Takeuchi H; Huang S; Umetani N; Koyanagi K; Hoon DS
    Cancer Res; 2005 Mar; 65(5):1800-7. PubMed ID: 15753377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
    Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
    BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
    Wang LQ; Wong KY; Li ZH; Chim CS
    Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
    Zhang YW; Staal B; Dykema KJ; Furge KA; Vande Woude GF
    PLoS One; 2012; 7(6):e38955. PubMed ID: 22701735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
    Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
    BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis.
    Zendman AJ; van Kraats AA; den Hollander AI; Weidle UH; Ruiter DJ; van Muijen GN
    Int J Cancer; 2002 Jan; 97(2):195-204. PubMed ID: 11774264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma.
    Bonazzi VF; Irwin D; Hayward NK
    Genes Chromosomes Cancer; 2009 Jan; 48(1):10-21. PubMed ID: 18803327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional modulation of IGF-binding protein-3 expression in melanoma.
    Dar AA; Majid S; Nosrati M; de Semir D; Federman S; Kashani-Sabet M
    J Invest Dermatol; 2010 Aug; 130(8):2071-9. PubMed ID: 20357812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative epigenomics of human and mouse mammary tumors.
    Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
    Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.